FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043986439> ?p ?o ?g. }

• W3043986439 endingPage "834" @default.
• W3043986439 startingPage "825" @default.
• W3043986439 abstract "Summary The nucleoside analogue, 2‐chlorodeoxyadenosine (2CDA), was reported to be an active treatment for childhood Langerhans cell histiocytosis (LCH) without risk organ (RO−) involvement. However, we lack data on long‐term effects of 2CDA treatment, including the disease reactivation rate, permanent sequelae and long‐term tolerance. This study included 44 children from the French LCH registry, treated for a RO− LCH with 2CDA monotherapy (median number of six courses). The median age at the beginning of 2CDA was 3·6 years (range, 0·3–19·7 years) and the median follow‐up after was 5·4 years (range, 0·6–15·1 years). Objective response to 2CDA was observed in 25 patients (56·8%), while six patients (13·6%) had stable disease and 13 patients (29·5%) exhibited progressive disease. Among patients without progression, only two experienced disease reactivation after 2CDA discontinuation. The five‐year cumulative incidence of disease progression or reactivation after 2CDA therapy initiation was 34·3%. The lymphopenia reported in all cases [72% below absolute lymphocyte count (ALC) of 0·5 G/l], was addressed with appropriate prophylactic measures. Other toxicities above grade 2 were uncommon, and no second malignant neoplasm or neuropathy was reported. The five‐year overall survival was 97·7%. In conclusion, we could confirm that 2CDA monotherapy was a beneficial long‐term therapy for treating patients with RO− LCH. Appropriate management of induced immune deficiency is mandatory." @default.
• W3043986439 created "2020-07-29" @default.
• W3043986439 creator A5006432878 @default.
• W3043986439 creator A5007907029 @default.
• W3043986439 creator A5009841489 @default.
• W3043986439 creator A5011669522 @default.
• W3043986439 creator A5012706246 @default.
• W3043986439 creator A5019781329 @default.
• W3043986439 creator A5021388465 @default.
• W3043986439 creator A5022786965 @default.
• W3043986439 creator A5026865805 @default.
• W3043986439 creator A5028292912 @default.
• W3043986439 creator A5029042248 @default.
• W3043986439 creator A5029547694 @default.
• W3043986439 creator A5033150447 @default.
• W3043986439 creator A5034965143 @default.
• W3043986439 creator A5039924900 @default.
• W3043986439 creator A5047723847 @default.
• W3043986439 creator A5048634689 @default.
• W3043986439 creator A5051569248 @default.
• W3043986439 creator A5062618437 @default.
• W3043986439 creator A5068486295 @default.
• W3043986439 creator A5070056011 @default.
• W3043986439 creator A5070179654 @default.
• W3043986439 creator A5073782592 @default.
• W3043986439 creator A5085174982 @default.
• W3043986439 creator A5089621837 @default.
• W3043986439 date "2020-07-22" @default.
• W3043986439 modified "2023-10-18" @default.
• W3043986439 title "Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment" @default.
• W3043986439 cites W121485390 @default.
• W3043986439 cites W1494664247 @default.
• W3043986439 cites W1507320147 @default.
• W3043986439 cites W1544153954 @default.
• W3043986439 cites W1839937968 @default.
• W3043986439 cites W1906996655 @default.
• W3043986439 cites W1981515606 @default.
• W3043986439 cites W2019607817 @default.
• W3043986439 cites W2027889680 @default.
• W3043986439 cites W2037259472 @default.
• W3043986439 cites W2037618016 @default.
• W3043986439 cites W2048765718 @default.
• W3043986439 cites W2069035104 @default.
• W3043986439 cites W2083168581 @default.
• W3043986439 cites W2094330363 @default.
• W3043986439 cites W2098746360 @default.
• W3043986439 cites W2107166045 @default.
• W3043986439 cites W2140365656 @default.
• W3043986439 cites W2159672704 @default.
• W3043986439 cites W2172043322 @default.
• W3043986439 cites W2295097092 @default.
• W3043986439 cites W2314659489 @default.
• W3043986439 cites W2316700455 @default.
• W3043986439 cites W2415837089 @default.
• W3043986439 cites W2474782031 @default.
• W3043986439 cites W2608885309 @default.
• W3043986439 cites W2895768742 @default.
• W3043986439 cites W2901362956 @default.
• W3043986439 cites W2912707964 @default.
• W3043986439 cites W2972707815 @default.
• W3043986439 cites W3010697726 @default.
• W3043986439 cites W31990271 @default.
• W3043986439 cites W4237223807 @default.
• W3043986439 cites W992317070 @default.
• W3043986439 doi "https://doi.org/10.1111/bjh.16944" @default.
• W3043986439 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32700439" @default.
• W3043986439 hasPublicationYear "2020" @default.
• W3043986439 type Work @default.
• W3043986439 sameAs 3043986439 @default.
• W3043986439 citedByCount "12" @default.
• W3043986439 countsByYear W30439864392020 @default.
• W3043986439 countsByYear W30439864392021 @default.
• W3043986439 countsByYear W30439864392022 @default.
• W3043986439 countsByYear W30439864392023 @default.
• W3043986439 crossrefType "journal-article" @default.
• W3043986439 hasAuthorship W3043986439A5006432878 @default.
• W3043986439 hasAuthorship W3043986439A5007907029 @default.
• W3043986439 hasAuthorship W3043986439A5009841489 @default.
• W3043986439 hasAuthorship W3043986439A5011669522 @default.
• W3043986439 hasAuthorship W3043986439A5012706246 @default.
• W3043986439 hasAuthorship W3043986439A5019781329 @default.
• W3043986439 hasAuthorship W3043986439A5021388465 @default.
• W3043986439 hasAuthorship W3043986439A5022786965 @default.
• W3043986439 hasAuthorship W3043986439A5026865805 @default.
• W3043986439 hasAuthorship W3043986439A5028292912 @default.
• W3043986439 hasAuthorship W3043986439A5029042248 @default.
• W3043986439 hasAuthorship W3043986439A5029547694 @default.
• W3043986439 hasAuthorship W3043986439A5033150447 @default.
• W3043986439 hasAuthorship W3043986439A5034965143 @default.
• W3043986439 hasAuthorship W3043986439A5039924900 @default.
• W3043986439 hasAuthorship W3043986439A5047723847 @default.
• W3043986439 hasAuthorship W3043986439A5048634689 @default.
• W3043986439 hasAuthorship W3043986439A5051569248 @default.
• W3043986439 hasAuthorship W3043986439A5062618437 @default.
• W3043986439 hasAuthorship W3043986439A5068486295 @default.
• W3043986439 hasAuthorship W3043986439A5070056011 @default.
• W3043986439 hasAuthorship W3043986439A5070179654 @default.
• W3043986439 hasAuthorship W3043986439A5073782592 @default.

• next